ELK3 expression as a prognostic marker in patients with glioma
ELK3 is established as an independent prognostic marker in gliomas, intimately linked with pivotal immune-related pathways. These insights highlight the potential of ELK3 as both a biomarker and a therapeutic target in the management of glioma, offering avenues for improved prognostic assessments and therapeutic strategies.
Authors
- Shanquan Jing
- Cong-Hui Li
- Li Wang (ORCID: https://orcid.org/0000-0002-4282-2454)
- Wei Liu (ORCID: https://orcid.org/0000-0002-2616-4869)
Institutions
- First Affiliated Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Neurological Research
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1080/01616412.2025.2490088
- Primary Topic
- RNA regulation and disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00